Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis L Moreira-Teixeira, PJ Stimpson, E Stavropoulos, S Hadebe, ... Nature communications 11 (1), 5566, 2020 | 150 | 2020 |
Characterisation of innate fungal recognition in the lung I Faro-Trindade, JA Willment, AM Kerrigan, P Redelinghuys, S Hadebe, ... PloS one 7 (4), e35675, 2012 | 61 | 2012 |
C-type lectin receptors in asthma S Hadebe, F Brombacher, GD Brown Frontiers in immunology 9, 733, 2018 | 50 | 2018 |
Microbial ligand costimulation drives neutrophilic steroid-refractory asthma S Hadebe, F Kirstein, K Fierens, K Chen, RA Drummond, S Vautier, ... PLoS One 10 (8), e0134219, 2015 | 48 | 2015 |
Immunoglobulin M in health and diseases: how far have we come and what next? K Jones, AF Savulescu, F Brombacher, S Hadebe Frontiers in Immunology 11, 595535, 2020 | 41 | 2020 |
β-Glucan exacerbates allergic airway responses to house dust mite allergen S Hadebe, F Kirstein, K Fierens, P Redelinghuys, GI Murray, DL Williams, ... Respiratory research 17, 1-3, 2016 | 31 | 2016 |
European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation A Budu-Aggrey, A Kilanowski, MK Sobczyk, 23andMe Research Team, ... Nature Communications 14 (1), 6172, 2023 | 23 | 2023 |
Respiratory viral and bacterial factors that influence early childhood asthma N Mthembu, P Ikwegbue, F Brombacher, S Hadebe Frontiers in Allergy 2, 692841, 2021 | 23 | 2021 |
Environment and host-genetic determinants in early development of allergic asthma: contribution of fungi S Hadebe, F Brombacher Frontiers in Immunology 10, 2696, 2019 | 21 | 2019 |
IL-4Rα signaling in CD4+ CD25+ FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33 J Khumalo, F Kirstein, S Hadebe, F Brombacher JCI insight 5 (20), 2020 | 18 | 2020 |
Therapeutic and prophylactic deletion of IL‐4Ra‐signaling ameliorates established ovalbumin induced allergic asthma J Khumalo, F Kirstein, M Scibiorek, S Hadebe, F Brombacher Allergy 75 (6), 1347-1360, 2020 | 16 | 2020 |
Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat Commun 11: 5566 L Moreira-Teixeira, PJ Stimpson, E Stavropoulos, S Hadebe, ... | 12 | 2020 |
Deletion of IL-4Rα signaling on B cells limits hyperresponsiveness depending on antigen load S Hadebe, J Khumalo, S Mangali, N Mthembu, H Ndlovu, M Scibiorek, ... Journal of Allergy and Clinical Immunology 148 (1), 99-109. e5, 2021 | 11 | 2021 |
Associations between environmental dust composition and atopic dermatitis in urban and rural settings T Trikamjee, W Basera, M Botha, HE Facey‐Thomas, B Gaunt, J Genuneit, ... Pediatric Allergy and Immunology 32 (5), 1013-1021, 2021 | 10 | 2021 |
IL-4Rα signalling in B cells and T cells play differential roles in acute and chronic atopic dermatitis M Scibiorek, N Mthembu, S Mangali, A Ngomti, P Ikwegbue, ... Scientific Reports 13 (1), 144, 2023 | 7 | 2023 |
Author Correction: IL-4Rα signalling in B cells and T cells play differential roles in acute and chronic atopic dermatitis M Scibiorek, N Mthembu, S Mangali, A Ngomti, P Ikwegbue, ... Scientific Reports 13 (1), 9651, 2023 | | 2023 |
Immunogenetics and pharmacogenetics of allergic asthma in Africa T Mabelane, R Masekela, C Dandara, S Hadebe Frontiers in Allergy 4, 1165311, 2023 | | 2023 |
Immunoglobulin M regulates airway hyperresponsiveness independent of T helper 2 allergic inflammation. S Hadebe, AF Savulescu, J Khumalo, K Jones, S Mangali, N Mthembu, ... bioRxiv, 2023.08. 02.551636, 2023 | | 2023 |
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug … AK Daramola, OA Akinrinmade, EA Fajemisin, K Naran, N Mthembu, ... Immunotherapy Advances 3 (1), ltac023, 2023 | | 2023 |
Targeting interleukin 4 receptor alpha in atopic dermatitis-focus on pre-clinical models S Hadebe, F Brombacher Current Allergy & Clinical Immunology 35 (2), 2-6, 2022 | | 2022 |